KLRG1 identifies circulating cytotoxic CD4 T cells with selective anti-tumor function in human cancer
This study identifies KLRG1 as a defining surface marker for circulating cytotoxic CD4+ T cells in melanoma patients that selectively kill MHC class II-expressing tumor cells via a granulysin-dependent mechanism while sparing antigen-presenting cells, and reveals that tumor-derived IL-6 impairs this function by driving a transition to a T follicular helper phenotype.
Cenerenti, M., Garnica, J., Saillard, M., Gueguen, P., Wolf, B., Lemaitre, F., Marone, R., Liu, Y. C., Cornu, A., Dumez, A., Sardiello, M. G., Pick, R., Jemelin, S., de Leval, L., Mueller, S., Valitut (…)2026-04-14🛡️ immunology